Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

European Trial of Immunosuppression in SPK Tx

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2005 by EUROSPK Study Group.
Recruitment status was  Active, not recruiting
Fujisawa GmbH
Hoffmann-La Roche
Wyeth is now a wholly owned subsidiary of Pfizer
Neovii Biotech
Genzyme, a Sanofi Company
Information provided by:
EUROSPK Study Group Identifier:
First received: August 31, 2005
Last updated: November 17, 2005
Last verified: August 2005
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2008
  Estimated Primary Completion Date: No date given